Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Lohmann

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
Virus Research|February 26, 2018
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agenciesRalf Bartenschlager, Thomas F Baumert, Jens Bukh, et al.
Journal of Hepatology|April 25, 2015
Control of temporal activation of hepatitis C virus-induced interferon response by domain 2 of nonstructural protein 5AMarie-Sophie Hiet, Oliver Bauhofer, Margarita Zayas, et al.
Journal of Hepatology|November 5, 2017
Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axisJulia Pollmann, Jana-Julia Götz, Daniel Rupp, et al.
Plos Pathogens|January 9, 2015
Identification of HNRNPK as regulator of hepatitis C virus particle productionMarion Poenisch, Philippe Metz, Hagen Blankenburg, et al.
Journal of Virology|August 14, 2015
DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell CultureOliver Grünvogel, Katharina Esser-Nobis, Anna Reustle, et al.
Plos Pathogens|December 5, 2012
Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitopeJulia Schmidt, Astrid K N Iversen, Stefan Tenzer, et al.
Frontiers in Immunology|July 5, 2022
Process Development for Adoptive Cell Therapy in Academia: A Pipeline for Clinical-Scale Manufacturing of Multiple TCR-T Cell ProductsDaniela Nascimento Silva, Michael Chrobok, Giulia Rovesti, et al.
Plos Pathogens|September 26, 2015
Modulation of the Host Lipid Landscape to Promote RNA Virus Replication: The Picornavirus Encephalomyocarditis Virus Converges on the Pathway Used by Hepatitis C VirusCristina M Dorobantu, Lucian Albulescu, Christian Harak, et al.
Nature Communications|August 13, 2021
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responsesQian Chen, Mairene Coto-Llerena, Aleksei Suslov, et al.
Biochemistry|May 24, 2017
Overall Structural Model of NS5A Protein from Hepatitis C Virus and Modulation by Mutations Confering Resistance of Virus Replication to Cyclosporin AAurelie Badillo, Véronique Receveur-Brechot, Stéphane Sarrazin, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
Virus Research|February 26, 2018
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agenciesRalf Bartenschlager, Thomas F Baumert, Jens Bukh, et al.
Journal of Hepatology|April 25, 2015
Control of temporal activation of hepatitis C virus-induced interferon response by domain 2 of nonstructural protein 5AMarie-Sophie Hiet, Oliver Bauhofer, Margarita Zayas, et al.
Journal of Hepatology|November 5, 2017
Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axisJulia Pollmann, Jana-Julia Götz, Daniel Rupp, et al.
Plos Pathogens|January 9, 2015
Identification of HNRNPK as regulator of hepatitis C virus particle productionMarion Poenisch, Philippe Metz, Hagen Blankenburg, et al.
Journal of Virology|August 14, 2015
DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell CultureOliver Grünvogel, Katharina Esser-Nobis, Anna Reustle, et al.
Plos Pathogens|December 5, 2012
Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitopeJulia Schmidt, Astrid K N Iversen, Stefan Tenzer, et al.
Frontiers in Immunology|July 5, 2022
Process Development for Adoptive Cell Therapy in Academia: A Pipeline for Clinical-Scale Manufacturing of Multiple TCR-T Cell ProductsDaniela Nascimento Silva, Michael Chrobok, Giulia Rovesti, et al.
Plos Pathogens|September 26, 2015
Modulation of the Host Lipid Landscape to Promote RNA Virus Replication: The Picornavirus Encephalomyocarditis Virus Converges on the Pathway Used by Hepatitis C VirusCristina M Dorobantu, Lucian Albulescu, Christian Harak, et al.
Nature Communications|August 13, 2021
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responsesQian Chen, Mairene Coto-Llerena, Aleksei Suslov, et al.
Biochemistry|May 24, 2017
Overall Structural Model of NS5A Protein from Hepatitis C Virus and Modulation by Mutations Confering Resistance of Virus Replication to Cyclosporin AAurelie Badillo, Véronique Receveur-Brechot, Stéphane Sarrazin, et al.
Pageof 12